checkAd

     109  0 Kommentare TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production - Seite 3

    Lesen Sie auch


    The Maravai LifeSciences Holdings Registered (A) Stock at the time of publication of the news with a fall of -5,84 % to 7,25EUR on Tradegate stock exchange (17. April 2024, 22:26 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production - Seite 3 TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility. The 32,000-square-foot facility …